Journal of Food and Nutrition Research
ISSN (Print): 2333-1119 ISSN (Online): 2333-1240 Website: https://www.sciepub.com/journal/jfnr Editor-in-chief: Prabhat Kumar Mandal
Open Access
Journal Browser
Go
Journal of Food and Nutrition Research. 2022, 10(10), 701-710
DOI: 10.12691/jfnr-10-10-8
Open AccessReview Article

Potential Role of Cinnamon (Cinnamomum verum) to Reduce the Risk of Polycystic Ovary Syndrome by Managing the Obesity: A Review

Sana Noreen1, Rabia Kanwal1, Abdul Rehman2, Ayesha Sadiqa3, Fizza Mubarak1, Madiha Khan Niazi1, Ahasan Ullah Khan4, 5 and Yunita Sari Pane6,

1University Institute of Diet and Nutritional Sciences, Faculty of Allied Health Sciences, University of Lahore Pakistan · Lahore, Pakistan

2Department of Medicine, Services Institute of Medical Sciences, Lahore, Pakistan

3Fatima Jinnah Medical University, Lahore, Pakistan

4Department of Entomology, Faculty of Agriculture, Sylhet Agricultural University, Sylhet, Bangladesh;

5Department of Agroforestry and Environmental Science, Climate-Smart Agriculture Lab, Faculty of Agriculture, Sylhet Agricultural University, Sylhet, Bangladesh

6Department of Pharmacology and Therapeutics, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia

Pub. Date: October 28, 2022

Cite this paper:
Sana Noreen, Rabia Kanwal, Abdul Rehman, Ayesha Sadiqa, Fizza Mubarak, Madiha Khan Niazi, Ahasan Ullah Khan and Yunita Sari Pane. Potential Role of Cinnamon (Cinnamomum verum) to Reduce the Risk of Polycystic Ovary Syndrome by Managing the Obesity: A Review. Journal of Food and Nutrition Research. 2022; 10(10):701-710. doi: 10.12691/jfnr-10-10-8

Abstract

The current study aims to assess the impact of obesity on polycystic ovary syndrome. It has a huge impact on the body, impacting physical, emotional, cognitive, and intellectual faculties. Diabetes mellitus, cardiovascular disease, endometrial cancer, and other clinical problems result. Insulin resistance, which refers to the process by which the body is unable to respond to insulin production sequentially, leading to a high level of triglycerides and cholesterol in the blood, is one of the most dangerous aspects studied in these individuals. Obesity is the leading cause of this condition, which is caused by an excessive buildup of fat in the body, which interferes with the body's natural functioning. Cardiovascular illnesses, which lead to a higher death rate globally, have a substantial relationship with PCOS. Women with PCOS have an increased amount of fatty tissues, which can worsen the condition and lead to type-II diabetes, stroke, and CVD. Physical manifestations of this heinous disease include acne, hirsutism, androgenetic alopecia, or male pattern baldness. Metabolic abnormalities contribute to the development and progression of PCOS and have major ramifications in later life that can be hazardous to health. It has been shown that even a 5% weight loss can reduce insulin and testosterone levels and improve fertility and menstrual cycle. Cinnamon has been shown to enhance menstrual cyclicity and insulin sensitivity in women with PCO. The purpose of this review is to investigate the efficacy of cinnamon supplementation in conjunction with specific lifestyle modifications, which has been proven to have potential therapeutic benefits against obesity and PCOS.

Keywords:
hormonal issues non-communicable diseases Cinnamon

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

Figures

Figure of 5

References:

[1]  Hart R, Doherty DA. The potential implications of a PCOS diagnosis on a woman’s long-term health using data linkage. The journal of clinical endocrinology & metabolism. 2015 Mar 1; 100(3): 911-9.
 
[2]  El Hayek S, Bitar L, Hamdar LH, Mirza FG, Daoud G. Poly cystic ovarian syndrome: an updated overview. Frontiers in physiology. 2016 Apr 5; 7: 124.
 
[3]  Palomba S, Falbo A, Daolio J, Battaglia FA, La Sala GB. Pregnancy complications in infertile patients with polycystic ovary syndrome: updated evidence. Minerva Ginecologica. 2018 Apr 11; 70(6): 754-60.
 
[4]  Chen ZJ, Shi Y, Sun Y, Zhang B, Liang X, Cao Y, Yang J, Liu J, Wei D, Weng N, Tian L. Fresh versus frozen embryos for infertility in the polycystic ovary syndrome. N engl j med. 2016 Aug 11; 375: 523-33.
 
[5]  Bagudu KA, Noreen S, Rizwan B, Bashir S, Khan M, Chishti K, Hussain S, Wahid S. Intermittent fasting effect on weight loss: a systematic review. Biosci Res. 2021; 18: 622-31.
 
[6]  Noreen S, Rizwan B, Khan M, Farooq S. Health benefits of Buckwheat (Fagopyrum esculentum), potential remedy for diseases, rare to cancer: A mini Review. Infectious Disorders-Drug Targets (Formerly Current Drug Targets-Infectious Disorders). 2021 Sep 1; 21(6): 15-20.
 
[7]  Malik S, Sheikh ZI, Kausar S, Ahmed N. Comparison of efficacy of spironolactone plus oral contraceptives with metformin in patients of PCOS with hirsutism. PAFMJ. 2018 Oct 30; 68(3): 460-65.
 
[8]  Borzoei A, Rafraf M, Niromanesh S, Farzadi L, Narimani F, Doostan F. Effects of cinnamon supplementation on antioxidant status and serum lipids in women with polycystic ovary syndrome. Journal of traditional and complementary medicine. 2018 Jan 1; 8(1): 128-33.
 
[9]  Laganà AS, Garzon S, Casarin J, Franchi M, Ghezzi F. Inositol in polycystic ovary syndrome: restoring fertility through a pathophysiology-based approach. Trends in endocrinology & metabolism. 2018 Nov 1; 29(11): 768-80.
 
[10]  Kumar S, Kumari R. Cinnamomum: review article of essential oil compounds, ethnobotany, antifungal and antibacterial effects. Open Access J Sci. 2019; 3(1): 13-6.
 
[11]  Dou L, Zheng Y, Li L, Gui X, Chen Y, Yu M, Guo Y. The effect of cinnamon on polycystic ovary syndrome in a mouse model. Reproductive Biology and Endocrinology. 2018 Dec; 16(1): 1-0.
 
[12]  Rodgers RJ, Avery JC, Moore VM, Davies MJ, Azziz R, Stener-Victorin E, Moran LJ, Robertson SA, Stepto NK, Norman RJ, Teede HJ. Complex diseases and co-morbidities: polycystic ovary syndrome and type 2 diabetes mellitus. Endocrine Connections. 2019 Mar 1; 8(3): R71-5.
 
[13]  Andrade M, Ribeiro-Santos R, Melo N, Sanches-Silva A. Bioactive compounds of cinnamon: a valuable aromatic plant for food packaging. InInternational Conference on Safety and Innovation in Food Packaging (InSIPack), 16 junho 2016 2016.
 
[14]  Vijayakumar K, Prasanna B, Rengarajan RL, Rathinam A, Velayuthaprabhu S, Vijaya Anand A. Anti-diabetic and hypolipidemic effects of Cinnamon cassia bark extracts: an in vitro, in vivo, and in silico approach. Archives of Physiology and Biochemistry. 2020 Sep 25: 1-1.
 
[15]  Sun P, Li K, Wang T, Ji J, Wang Y, Chen KX, Jia Q, Li YM, Wang HY. Procyanidin C1, a component of cinnamon extracts, is a potential insulin sensitizer that targets adipocytes. Journal of Agricultural and Food chemistry. 2019 Jul 23; 67(32): 8839-46.
 
[16]  Patil M, Choudhari AS, Pandita S, Islam MA, Raina P, Kaul-Ghanekar R. Cinnamaldehyde, cinnamic acid, and cinnamyl alcohol, the bioactives of Cinnamomum cassia exhibit HDAC8 inhibitory activity: an in vitro and in silico study. Pharmacognosy Magazine. 2017 Oct; 13(Suppl 3): S645.
 
[17]  Anderson RA, Zhan Z, Luo R, Guo X, Guo Q, Zhou J, Kong J, Davis PA, Stoecker BJ. Cinnamon extract lowers glucose, insulin and cholesterol in people with elevated serum glucose. Journal of traditional and complementary medicine. 2016 Oct 1; 6(4): 332-6.
 
[18]  Gunawardena D, Karunaweera N, Lee S, van Der Kooy F, Harman DG, Raju R, Bennett L, Gyengesi E, Sucher NJ, Münch G. Anti-inflammatory activity of cinnamon (C. zeylanicum and C. cassia) extracts–identification of E-cinnamaldehyde and o-methoxy cinnamaldehyde as the most potent bioactive compounds. Food & function. 2015; 6(3): 910-9.
 
[19]  Kwon H, Lee JJ, Lee JH, Cho WK, Gu MJ, Lee KJ, Ma JY. Cinnamon and its components suppress vascular smooth muscle cell proliferation by up-regulating cyclin-dependent kinase inhibitors. The American Journal of Chinese Medicine. 2015 Jun 29; 43(04): 621-36.
 
[20]  Furlan CP, Valle SC, Maróstica Jr MR, Östman E, Björck I, Tovar J. Effect of bilberries, lingonberries and cinnamon on cardiometabolic risk-associated markers following a hypercaloric-hyperlipidic breakfast. Journal of functional foods. 2019 Sep 1; 60: 103443.
 
[21]  Ibáñez L, Oberfield SE, Witchel S, Auchus RJ, Chang RJ, Codner E, Dabadghao P, Darendeliler F, Elbarbary NS, Gambineri A, Rudaz CG. An international consortium update: pathophysiology, diagnosis, and treatment of polycystic ovarian syndrome in adolescence. Hormone research in paediatrics. 2017; 88: 371-95.
 
[22]  Fernandez RC, Moore VM, Van Ryswyk EM, Varcoe TJ, Rodgers RJ, March WA, Moran LJ, Avery JC, McEvoy RD, Davies MJ. Sleep disturbances in women with polycystic ovary syndrome: prevalence, pathophysiology, impact and management strategies. Nature and science of sleep. 2018; 10: 45.
 
[23]  Zou J, Wu D, Liu Y, Tan S. Association of luteinizing hormone/choriogonadotropin receptor gene polymorphisms with polycystic ovary syndrome risk: a meta-analysis. Gynecological Endocrinology. 2019 Jan 2; 35(1): 81-5.
 
[24]  Thathapudi S, Kodati V, Erukkambattu J, Addepally U, Qurratulain H. Association of luteinizing hormone chorionic gonadotropin receptor gene polymorphism (rs2293275) with polycystic ovarian syndrome. Genetic testing and molecular biomarkers. 2015 Mar 1; 19(3): 128-32.
 
[25]  Owens LA, Kristensen SG, Lerner A, Christopoulos G, Lavery S, Hanyaloglu AC, Hardy K, Yding Andersen C, Franks S. Gene expression in granulosa cells from small antral follicles from women with or without polycystic ovaries. The Journal of Clinical Endocrinology & Metabolism. 2019 Dec; 104(12): 6182-92.
 
[26]  Tufail T, Ijaz A, Noreen S, Arshad MU, Gilani SA, Bashir S, Din A, Shahid MZ, Khan AA, Khalil AA, Awuchi CG. Pathophysiology of Obesity and Diabetes. InDietary Phytochemicals 2021 (pp. 29-42). Springer, Cham.
 
[27]  Gebara N, Kim JY, Tapanainen J, Morin-Papunen L, Arslanian S. OR33-1 Metabolic Inflexibility in Obese versus Lean Women with Polycystic Ovary Syndrome (PCOS): Is PCOS Status or Adiposity the Critical Factor?. Journal of the Endocrine Society. 2019 Apr;3(Supplement_1): OR33-1.
 
[28]  Barber TM, Joharatnam J, Franks S. Pathogenesis and management of adiposity and insulin resistance in polycystic ovary syndrome (PCOS). InPediatric Obesity 2018 (pp. 629-642). Humana Press, Cham.
 
[29]  Greenwood E, Sroga-Rios J, Pavone M, Cedars M, Legro RS, Huddleston HG. Putative role for adiposity reducing antimullerian hormone production in polycystic ovary syndrome and community controls. Fertility and Sterility. 2018 Sep 1; 110(4): e123-4.
 
[30]  Mubarak SM, Ali HA. Phenotypes and Complications of Polycystic Ovary Syndrome: A Rapid Update: a review. Annals of Tropical Medicine and Public Health. 2020 Jun; 23: 23-1040.
 
[31]  Forslund M, Landin-Wilhelmsen K, Krantz E, Trimpou P, Schmidt J, Brännström M, Dahlgren E. No difference in quality of life or depression/anxiety diagnosis between middle-aged women with PCOS and age-matched controls. Maturitas. 2019 Jun 1; 124: 154.
 
[32]  Shandley LM, Fothergill A, Spencer JB, Mertens AC, Cottrell HN, Howards PP. Impact of cancer treatment on risk of infertility and diminished ovarian reserve in women with polycystic ovary syndrome. Fertility and sterility. 2018 Mar 1; 109(3): 516-25.
 
[33]  Adeghate E, Mohsin S, Adi F, Ahmed F, Yahya A, Kalász H, Tekes K, Adeghate EA. An update of SGLT1 and SGLT2 inhibitors in early phase diabetes-type 2 clinical trials. Expert opinion on investigational drugs. 2019 Sep 2; 28(9): 811-20.
 
[34]  Mousavi SM, Jalilpiran Y, Karimi E, Aune D, Larijani B, Mozaffarian D, Willett WC, Esmaillzadeh A. Dietary intake of linoleic acid, its concentrations, and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of prospective cohort studies. Diabetes Care. 2021 Sep 1; 44(9): 2173-81.
 
[35]  Moraes FD, Dubois Filho DG, Caliari ÁI, Brasil GA, do Nascimento AM, Kalil IC, Scherer R, Endringer DC, Lenz D, de Lima EM, de Andrade TU. Chronic treatment with cinnamaldehyde prevents spontaneous atherosclerotic plaque development in ovariectomized LDLr-/-female mice. Pharma Nutrition. 2020 Sep 1; 13: 100205.
 
[36]  Husain I, Ahmad R, Chandra A, Raza ST, Shukla Y, Mahdi F. Phytochemical characterization and biological activity evaluation of ethanolic extract of Cinnamomum zeylanicum. Journal of ethnopharmacology. 2018 Jun 12; 219: 110-6.
 
[37]  Tarkhan MM, Balamsh KS, El‐Bassossy HM. Cinnamaldehyde protects from methylglyoxal‐induced vascular damage: Effect on nitric oxide and advanced glycation end products. Journal of food biochemistry. 2019 Jul; 43(7): e12907.
 
[38]  Kang YH, Kang JS, Shin HM. Vasodilatory effects of cinnamic acid via the nitric oxide–cGMP–PKG Pathway in rat thoracic aorta. Phytotherapy Research. 2013 Feb; 27(2): 205-11.
 
[39]  Yang L, Wu QQ, Liu Y, Hu ZF, Bian ZY, Tang QZ. Cinnamaldehyde attenuates pressure overload-induced cardiac hypertrophy. International journal of clinical and experimental pathology. 2015; 8(11): 14345.
 
[40]  Wang F, Pu C, Zhou P, Wang P, Liang D, Wang Q, Hu Y, Li B, Hao X. Cinnamaldehyde prevents endothelial dysfunction induced by high glucose by activating Nrf2. Cellular Physiology and Biochemistry. 2015; 36(1): 315-24.
 
[41]  Nour OA, Shehatou GS, Rahim MA, El-Awady MS, Suddek GM. Cinnamaldehyde exerts vasculoprotective effects in hypercholestrolemic rabbits. Naunyn-Schmiedeberg's Archives of Pharmacology. 2018 Nov; 391(11): 1203-19.
 
[42]  Heydarpour F, Hemati N, Hadi A, Moradi S, Mohammadi E, Farzaei MH. Effects of cinnamon on controlling metabolic parameters of polycystic ovary syndrome: A systematic review and meta-analysis. Journal of ethnopharmacology. 2020 May 23; 254: 112741.
 
[43]  Khan AU, Khan AU, Khanal S, Subodh Gyawali. Insect pests and diseases of cinnamon (Cinnamomum verum Presi.) and their management in agroforestry system: A review. Acta Entomology and Zoology 2020; 1(2): 51-59.
 
[44]  Mollazadeh H, Hosseinzadeh H. Cinnamon effects on metabolic syndrome: a review based on its mechanisms. Iranian journal of basic medical sciences. 2016 Dec; 19(12): 1258.
 
[45]  Pulungan A and Pane YS. The benefit of cinnamon (Cinnamomum burmannii) in lowering total cholesterol levels after consumption of high-fat containing foods in white mice (Mus musculus) models [version 2; peer review:2 approved]. F1000Research. 2020, 9: 168.
 
[46]  Lu M, Cao Y, Xiao J, Song M, Ho CT. Molecular mechanisms of the anti-obesity effect of bioactive ingredients in common spices: a review. Food & function. 2018; 9(9): 4569-81.
 
[47]  Nawaz HH, Farooq S, Rizwan B, Noreen S, Azhar S, Bukht H, Fatima A, Ashraf A, Abid F. Junk and Fast Food Consumption among Obese University Students.